
Aspire Pharmaceuticals Private Limited
Pharmaceutical company that manufactures, distributes, and trades various formulations and products.
Pharmaceutical company that manufactures, distributes, and trades various formulations and products.
Aspire Pharmaceuticals Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 November 2020 (Four years and six months 0 days old ). Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.72 Cr.
The company currently has active open charges totaling ₹20.00 Cr.
Ashish Chopda, Rishabh Chopda, Naveen Deshlahara, and One other member serve as directors at the Company.
Raipur, Chattisgarh, India
+91-XXXXXXXXXX
U24110CT2020PTC010922
010922
Private Limited Indian Non-Government Company
12 Nov 2020
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chhattisgarh
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashish Chopda ![]() | Director | 12-Nov-2020 | Current |
Rishabh Chopda ![]() | Director | 12-Nov-2020 | Current |
Naveen Deshlahara ![]() | Director | 01-Mar-2023 | Current |
Usha Sharma ![]() | Director | 01-Mar-2023 | Current |
Aspire Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2023, Aspire Pharmaceuticals had a public holding of 39.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ashish Chopda and Rishabh Chopda are mutual person
Ashish Chopda and Rishabh Chopda are mutual person
₹20.00 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
22 Dec 2023 | Sidbi | ₹20.00 Cr | Open |
Aspire Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aspire Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Sidbi amounted to Rs. 20.00 Cr with Charge ID 100835264 was registered on 22 Dec 2023.
Aspire Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Aspire Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chhattisgarh.
Naveen Deshlahara was appointed as a Director was appointed as a Director on 01 Mar 2023 & has been associated with this company since 2 years 2 months .
Usha Sharma was appointed as a Director was appointed as a Director on 01 Mar 2023 & has been associated with this company since 2 years 2 months .
Ashish Chopda was appointed as a Director was appointed as a Director on 12 Nov 2020 & has been associated with this company since 4 years 6 months .
Aspire Pharmaceuticals Private Limited was incorporated on 12 Nov 2020.
The authorized share capital of Aspire Pharmaceuticals Private Limited is ₹ 6.00 Cr and paid-up capital is ₹ 4.72 Cr.
Currently 4 directors are associated with Aspire Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Aspire Pharmaceuticals Private Limited is Plot No.11 Kedia Business Park Tatibandh, India, Raipur, Chattisgarh, 492001.
The corporate identification number (CIN) of Aspire Pharmaceuticals Private Limited is U24110CT2020PTC010922 and the company number is 010922 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2023, The total open charges for Aspire Pharmaceuticals Private Limited amount to ₹ 20.00 Cr.
The most recent Balance Sheet for Aspire Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
AD
RD
AS